Markey, Chloe
Croset, Samuel
Woolley, Olivia Ruth
Buldun, Can Martin
Koch, Christian http://orcid.org/0009-0003-4741-4171
Koller, Daniel http://orcid.org/0009-0002-3388-3295
Reker, Daniel http://orcid.org/0000-0003-4789-7380
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (R35GM151255, NIH T32 GM133352-4)
Article History
Received: 3 August 2023
Accepted: 12 January 2024
First Online: 26 February 2024
Competing interests
: D.R. acts as a consultant to the pharmaceutical and biotechnology industry, as a scientific mentor for the German Accelerator, and serves on the scientific advisory board of Areteia Therapeutics. S.C., O.R.W., C.M.B., C.K. and D.K. are employees of Bellevue Asset Management and members of the investment team BB Biotech, with investments in the biotechnology industry including some of the companies analyzed here—a full list of the portfolio is available at ExternalRef removed.